B-NHL 2013 - Treatment protocol of the NHL-BFM and the NOPHO study groups for mature aggressive B-cell lymphoma and leukemia in children and adolescents
Phase of Trial: Phase III
Latest Information Update: 11 Nov 2017
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Cytarabine; Dexamethasone; Dexamethasone; Doxorubicin; Etoposide; Ifosfamide; Methotrexate; Methotrexate; Prednisolone; Vincristine; Vindesine
- Indications Burkitt's lymphoma; Diffuse large B cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Acronyms B-NHL 2013
- 22 Aug 2017 Planned End Date changed from 1 Jul 2024 to 1 Aug 2024.
- 22 Aug 2017 Planned primary completion date changed from 1 Jul 2024 to 1 Aug 2024.
- 22 Aug 2017 Status changed from not yet recruiting to recruiting.